fbpx
© The Rialto Consultancy
BETA
v1.0
menu menu

Log on to your account

Forgotten password | Register

Welcome

Logout
Home | News & Insight | Vancouver biotech developing COVID-19 drug like the one used to treat Trump soars in blockbuster IPO

Vancouver biotech developing COVID-19 drug like the one used to treat Trump soars in blockbuster IPO

11th Dec 2020 | 07:55pm
A Canadian biotech company that’s on the leading edge of COVID-19 therapies saw its stock price soar 185 per cent on its debut on Friday on the Nasdaq stock exchange. Read More
Innovation
Exclusive: In the race for robot training data, ex-Meta researchers’ startup turns to gig workers with cameras
Leadership
Bots in the boardroom: Could an AI ever replace board directors?